T11TS immunotherapy potentiates the repressed calcineurin-NFAT signalling pathway of T cells in Cryptococcus neoformans infected rats: a cue towards T-cell activation for antifungal immunity

J Appl Microbiol. 2020 Sep;129(3):753-767. doi: 10.1111/jam.14631. Epub 2020 Apr 7.

Abstract

Aims: To examine the modulation of the interacting partners of the calcineurin (CaN)-NFAT pathway in T cells during Cryptococcus neoformans fungal infection and post-T11TS immunotherapy.

Methods and results: Wistar rats were infected with C. neoformans and followed by immunotherapy with immune-potentiator T11TS. T cells were analysed by flow cytometry, immunoblotting and nuclear translocation study. The signalling proteins LCK, FYN, LAT, PLCγ1 and CaN in T cells were regulated by C. neoformans infection resulting in reduced nuclear translocation of NFAT and IL-2 expression. Following T11TS immunotherapy, the expressions of the above-mentioned proteins were boosted and thus resulting in the clearance of C. neoformans from lung and spleen.

Conclusions: The precise mechanism of suppression of the T-cell function by C. neoformans is still unknown. Previously, we have shown that T11TS positively regulates the function of T cells to abrogate glioma and other immunosuppressive conditions. T11TS immunotherapy increased the expression of the above signalling partners of the CaN-NFAT pathway in T cells and improved nuclear retention of NFAT. As a result, an increased IL-2 expression leads to activation and proliferation of T cells.

Significance and impact of the study: Our results demonstrate the role of T11TS in restoring the CaN-NFAT signalling pathway in T cells. It identifies T11TS as an immunotherapeutic agent with potential clinical outcomes to counteract C. neoformans infection.

Keywords: Cryptococcus neoformans; IL-2; NFAT; T cell; T11 target structure; immunotherapy; signalling.

MeSH terms

  • Animals
  • CD58 Antigens / therapeutic use*
  • Calcineurin / metabolism*
  • Cryptococcosis / immunology
  • Cryptococcosis / microbiology
  • Cryptococcosis / therapy*
  • Cryptococcus neoformans / drug effects
  • Cryptococcus neoformans / immunology
  • Immunotherapy / methods
  • Interleukin-2 / metabolism
  • Lymphocyte Activation / drug effects
  • NFATC Transcription Factors / metabolism*
  • Rats
  • Rats, Wistar
  • Sheep
  • Signal Transduction / drug effects
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism

Substances

  • CD58 Antigens
  • Interleukin-2
  • NFATC Transcription Factors
  • T11TS protein, sheep
  • Calcineurin